MPO and periodontal disorder: Furthermore, the model presented may elucidate important CHD biomarkers which should be measured in patients with periodontal disease to more adequately screen for CHD risk, namely HOMA, TNF-α, CRP, IL-6, GDF-15, OPG, MPO and fibrinogen.